Kar, DebasishByng, RichardSheikh, AzizNath, MintuZabeen, BedowraKar, ShubharthiBanu, ShakilaSarker, Mohammad Habibur RahmanKhan, NavidAcharjee, DurjoyIslam, ShafiqulAllgar, VictoriaOrdóñez-Mena, José M.El-Wazir, AyaSong, SoonVerma, AshishKadam, Umeshde Lusignan, Simon2025-10-212025-04-01Kar, D, Byng, R, Sheikh, A, Nath, M, Zabeen, B, Kar, S, Banu, S, Sarker, M H R, Khan, N, Acharjee, D, Islam, S, Allgar, V, Ordóñez-Mena, J M, El-Wazir, A, Song, S, Verma, A, Kadam, U & de Lusignan, S 2025, 'Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome : insights from the UK Biobank cohort', BMC Nephrology, vol. 26, 168. https://doi.org/10.1186/s12882-025-04090-71471-2369RIS: urn:8772C9F258F39152511DC76CEA2E1881RIS: Kar2025ORCID: /0000-0002-0753-0464/work/182641950https://hdl.handle.net/2164/26263A Correction to this article was published on 14 May 2025. Correction: BMC Nephrology (2025) 26:168 This research was conducted using the UK Biobank resource under application No 61894. For the purpose of open access, the authors have applied a Creative Commons Attribution (CC BY) license to any arising Author Accepted Manuscript version. When appropriate, AI software ChatGPT was used to improve readability without any impact on the study findings and its interpretation.111799045engSDG 3 - Good Health and Well-beingChronic kidney diseaseDiabetesEnd-stage kidney disease (ESKD)Renal replacement therapy (RRT)R Medicine (General)Supplementary DataDASLinkR1Journal article10.1186/s12882-025-04090-7https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-04151-x